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Abstract
Background: Most estimates of postpartum hemorrhage (PPH) are calculated from studies that use administrative
or medical birth databases, and only a few from prospective observational studies.
Our principal objective was to estimate the incidence of PPH according to their severity (mild or severe) in vaginal
deliveries (>500 mL, ≥1000 mL) and cesareans (>1000 mL and ≥1500 mL). The secondary objectives were to
describe the incidence of PPH according to maternity unit characteristics, causes, and types of PPH management.
Methods: This prospective observational study took place in French maternity wards. Women who gave birth at a
term≥ 22 weeks were eligible for the study. 182 maternity units participated in a study with prospective data
collection from 1 February, 2011, to 31 July, 2011. The main outcome measure was PPH incidence.
Results: PPH incidence after vaginal delivery was 3.36 % [95 % CI: 3.25–3.47 %] and after cesareans 2.83 %
[95 % CI: 2.63–3.04 %]. The incidence of severe PPH after vaginal delivery was 1.11 % [95 % CI: 1.05–1.18 %]
and after cesareans 1.00 % [95 % CI: 0.88–1.13 %]. This incidence rate varied according to maternity unit
characteristics. The principal cause of PPH for both modes of delivery was uterine atony (57.7 % for vaginal
births and 66.3 % for cesareans). Vascular embolization was more frequent among women with cesareans
(10.0 vs. 2.9 %), who also required transfusions more often (44.4 vs 12.7 %).
Conclusions: The incidence of PPH was lower than the rate expected from the literature. Effective treatment
of uterine atony and optimizing the identification of blood loss remain important priorities.
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Background
Postpartum hemorrhage (PPH) remains a major cause of
maternal deaths worldwide [1, 2]. In France, PPH was
the leading cause of death, responsible for 18 % of
maternal deaths in the decade from 1998 to 2007 [3].
Hemorrhage-related events are among the most prevent-
able causes of maternal death.
Previous studies have suggested that severe maternal
morbidity may be a better indicator of the quality of
obstetric care, particularly in developed countries where
maternal mortality is rare [4–9]. Obstetric hemorrhage
is the main cause of severe maternal morbidity [6, 7, 10].
There is, however, no universally accepted definition of
PPH [11, 12]. Accordingly, definitions using various
levels of estimated blood loss [7, 13–19], various quan-
tities of transfused blood [7, 16], specific decreases in
postpartum hemoglobin [7, 20], or composite criteria
[16, 20–22] have all been used in previous publications.
The prevalence of PPH (defined as ≥500 mL blood
loss) and severe PPH (defined as ≥1 000 mL blood loss)
are reported to be around 6.0 and 1.86 % of all deliveries,
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respectively, and vary widely throughout the world [23].
Most estimates are calculated from observational studies
that use administrative or medical birth databases [14,
17–19, 24–29]; only a few come from prospective obser-
vational studies [15, 20, 30]. Of the two French
population-based studies [20, 31], only one was prospect-
ive, conducted in 16 of the 33 maternity units of the
Rhône-Alpes perinatal network in 2004–2005 [20]. The
overall incidence of immediate PPH was 5.4 ± 0.3 %, but
the diagnosis was clinical in 82.5 % of the severe cases and
in 77.5 % of milder ones; the remainder were detected by
postpartum laboratory tests [20]. A broader incidence
study therefore appeared useful, one that would include
several French regions, be supported by French perinatal
networks, and for which all participating professionals
would apply a standard definition of PPH.
The principal objective of this study was to estimate
the incidence of PPH, as either relatively mild or severe,
in vaginal (>500 mL and ≥1000 mL) and cesarean
(>1000 mL and ≥1500 mL) deliveries. The secondary
objectives were to describe the incidence of PPH accord-
ing to characteristics of the maternity units, causes, and
types of PPH management.
Methods
Materials
This prospective observational study was approved by
a French institutional review board (Comité d’Ethique
des Centres d’Investigation Clinique de l’Inter-région
Rhônes-Alpes-Auvergne, Grenoble: CECIC): IRB 0917
on 9 November 2009]. Our study adhered to STROBE
guidelines. All patients were informed about the study
and that neither participation in it nor refusal to con-
sent would affect their treatment, which would be the
usual standard of care.
Eligible women had singleton or multiple pregnancies,
regardless of parity, delivered stillborn or live born
babies in a participating maternity unit by vaginal or
cesarean delivery, at or after a gestation of 22 weeks (or,
in the absence of a specific date for the beginning of the
pregnancy, birth of a child ≥500 g).
Data source
We contacted 43 French perinatal networks to request
their support for this study of their maternity units.
Twenty perinatal networks, covering 231 eligible ma-
ternity units, agreed to support this 6-month project
(1 February 2011 to 31 July 2011). Finally, 182 maternity
units participated, for a participation rate of 78.79 %
maternity units (84 level I, 69 level II and 29 level III). In
10 perinatal networks (50 % of those participating), all of
the network’s maternity units participated. Table 1 com-
pares the characteristics of the French maternity units that
participated and those that did not.
In each case of postpartum hemorrhage (defined as
blood loss >500 mL for vaginal delivery and >1000 mL
for cesareans in the 24 h after delivery), the medical
and/or surgical treatment and maternal outcomes
were recorded. Blood loss was to be estimated visu-
ally with the habitual method used in each unit and
specified in each woman’s records. Professionals in
each unit collected data prospectively for 6 months,
entering it onto electronic case report forms via a
secure website.
The principal endpoint was the incidence of PPH.
Quality control was performed in 30 % of the mater-
nity units in each participating network, selected by
random drawing, from September 2011 to November
2012. In each of the selected maternity wards, 10 % of
the study files (again, randomly selected) were verified
manually as were the birth registers, either by a super-
visor of the perinatal network or by one of the two
midwives coordinating the study nationwide. One ma-
ternity ward was excluded from the statistical analysis
because it refused to participate in the quality control
procedure. Finally 53 maternity units were audited (and
108 records verified).
Table 1 Comparison of the characteristics of French maternity









< 250 7.7 11.4 0.12
250–749 58.0 49.9
≥ 750 34.3 38.7
Level of carec
Level I 45.9 50.1 0.22
Level II 38.1 38.2
Level III 16.0 11.7
Type of facility
University hospital 8.8 8.8 0.02
General hospital 64.1 52.5
Private hospital 27.1 38.7
Regiond
Province 82.9 82.8 0.97
Île de France 17.1 17.2
aMaternity units that did not participate in the study among all French
maternity units, according to 2010 healthcare facility statistics
bDelivery during the 6-month study period
cLevel I: no neonatology department. Level II: presence of a department of
neonatology and special care in the same building or immediate proximity to
the site of delivery. Level III: neonatal intensive care present in the same
building (in addition to neonatology units) or immediate proximity to the
delivery room
dIle de France includes Paris and its metropolitan area. Province is all other
French regions
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Statistical analysis
The χ2 test (or Fisher’s exact test when appropriate) was
used to compare the qualitative variables and Student’s t
test for the quantitative variables. Clinically relevant
crude relative risks (RR) were calculated (cesareans com-
pared with vaginal deliveries), with their 95 % confidence
intervals (95 % CI). The analysis was performed with
STATA software (version 13, Statacorp, College Station,
TX, US). A P value < .05 was considered significant.
Results
Table 2 describes the women’s medical characteristics.
Women in the cesarean group were older, gave birth at
an earlier gestational age, and had more multiple preg-
nancies (P < .001).
During the study period there were 129,110 deliveries
in the participating maternity units (103,733 vaginal and
25,377 cesarean) with 4207 PPH reported, including
3488 after vaginal delivery, 714 PPH after cesareans, and
5 after a cesarean performed on the second twin.
The incidence of PPH (>500 mL) after vaginal delivery
was 3.36 % [95 % CI: 3.25–3.47 %] and after cesareans
(>1000 mL) 2.83 % [9 5% CI: 2.63–3.04 %]. The inci-
dence of severe PPH after vaginal delivery (≥1000 mL)
was 1.11 % [95 % CI: 1.05–1.18] and after cesareans
(≥1500 mL) 1.0 % [95 % CI: 0.88–1.13 %].
For vaginal deliveries, the incidence of transfusions
among the women with mild PPH (>500 mL and <
1000 mL) was 4.95 % [95 % CI: 4.08–5.93], and among
those with severe PPH 28.45 % [95 % CI: 25.87–31.13].
For the cesareans, the incidence of transfusions with mild
PPH (>1000 mL and < 1500 mL) was 33.16 % [95 % CI:
28.54–38.05] and among those with severe PPH 64.54 %
[95 % CI: 58.28–70.46].
The incidence of PPH varied according to maternity
unit characteristics (number of deliveries, type of hos-
pital, and region) for cesareans (P < .003) and for vaginal
deliveries (P < .001) (except for the number of deliveries)
(Table 3).
The principal cause of PPH for both modes of delivery
was uterine atony (57.7 % for vaginal births and 66.3 %
for cesareans) (Table 4). The second and third leading
causes of PPH after vaginal delivery were, respectively,
placental retention (38.7 %) and perineal tears and lacera-
tions (24.9 %). For cesareans, the second leading cause
was surgical complications (16.4 %) and the third abnor-
malities of placental insertion (12.7 %). Finally, in 8.5 % of
the PPH after cesareans, the cause was not determined
Table 2 Description of medical data of women who had a PPH
Women with PPH Vaginal delivery and PPH
n = 3488
% [mean ± SD]
Cesarean and PPH
n = 719
% [mean ± SD]
p value
Delivery at term (weeks) [39.7 ± 2.2] [38.3 ± 3.1] <.0001
Singletons 96.8 87.7 <.0001
Women’s age
< 18 years 0.8 0.1 <.0001
18–35 years 83.5 70.7
≥ 35 years 15.7 29.2




































aTo participate in the study, blood loss had to be estimated visually but additional modes of estimation used in the maternity units were also considered. The
estimate of blood loss could requires various combined methods of measurement, such as aspiration and the weighing of compresses during a cesarean
bActive management of the third stage of labor was defined as the use of uterotonic agents after childbirth. It was performed in 73.7 % of the cesareans with PPH
immediately after birth and in 25.6 % of cases after delivery of the placenta. In vaginal deliveries, active management of the third stage of labor began at the
emergence of the anterior shoulder in 91.5 % of cases, immediately after birth in 7.3, and in 0.9 % of cases after placental delivery
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(vs. 1.6 % in vaginal deliveries). The risk of uterine atony
was 1.15 times more frequent [95%CI: 1.08–1.22] and the
risk of intraoperative complications 190 times more fre-
quent [95 % CI: 60.84–598.46] for cesarean compared
with vaginal deliveries (Table 4). When we limited the
comparison of PPH for the 2 types of delivery by defining
them by the same volume of blood loss (>1000 mL), the
results pointed in the same direction (except for uterine
atony, which no longer differed according to mode of deli-
very)[data not shown] (see Additional file 1: Table S1).
The estimate of blood loss was more often subjective for
cesarean than vaginal deliveries (38.9 vs. 21.5 %) (P < .0001);
similarly use of active management of the third stage of
labor (injection of uterotonic agents) was more frequent for
cesareans (90.7 vs. 79.8 %) (P < .0001) (Table 2). Oxytocin
was the uterotonic used after cesareans in 86.7 % of the
cases, with carbetocin used in 13.3 %. Oxytocin was used in
98.4 % of the PPH after vaginal deliveries.
Women with PPH after vaginal delivery received the
following pharmacological products: oxytocin in 89.8 %
of cases (n = 3473), prostaglandins in 33.0 % (n = 3472),
fibrinogen in 2.8 % (n = 3473), factor VIIa in 0.5 %
(n = 3472), and tranexamic acid in 5.1 % (n = 3473).
After cesareans, they received oxytocin in 76.6 % (n = 709),
prostaglandins in 57.1 % (n = 711), fibrinogen in 10.8 %
(n = 711), factor VIIa in 1.1 % (n = 711), and tranexamic
acid in 14.3 % (n = 711).




% [95 % CI]
p value n = 25,377
% [95 % CI]
p value
No. deliveriesa
< 250 3.84 [3.07–4.73] .11 1.31 [0.53–2.69] <.001
250–749 3.23 [3.06–3.41] 2.20 [1.92–2.51]
> 750 3.43 [3.29–3.58] 3.29 [3.01–3.59]
Levelb
I 2.77 [2.58–2.96] < .001 1.94 [1.63–2.29] <.001
II 3.26 [3.09–3.44] 2.50 [2.21–2.83]
III 4.05 [3.83–4.27] 4.05 [3.63–4.51]
Regionc
Ile de France 2.78 [2.57–3.01] < .001 2.27 [1.91–2.68] .003
Province 3.52 [3.39–3.65] 3.01 [2.77–3.26]
aNumber of deliveries during the 6-month study period
bLevel I: no neonatology department. Level II: presence of a department of
neonatology and special care in the same building or immediate proximity to
the site of delivery. Level III: neonatal intensive care present in the same
building (in addition to neonatology units) or immediate proximity to the
delivery room
cIle de France includes Paris and its metropolitan area. Province: all other
French regions
Table 4 Causes of PPH according to mode of delivery






Crude RRb [95 % CI] p value
Uterine atony 57.7 66.3 1.15 [1.08–1.22] <.0001
Placental retention 38.7 2.6 0.07 [0.04–0.11] <.0001
Vaginal and/or perineal lacerations 24.9 1.7 - -
Episiotomy 19.4 0.8 - -
Anomaly of placental insertion 1.9 12.7 - -
Uterine rupturec 0.4 1.7 4.15 [1.93–8.95] -
Cervical lacerations 3.4 0.8 - -
Vaginal thrombus 1.3 0.4c - -
Others
intraoperative complications 0.1 16.4 190.81 [60.84–598.46] <.0001
hemorrhagic normal 3rd staged 0.3 0.1 - -
amniotic fluid embolism 0.1 0.1 - -
uterine inversion 0.1 0.0 - -
coagulation disorders 0.2 2.6 - -
not determinede 1.6 8.5 - -
aOne woman could have had several causes that explain her PPH
bcesareans vs. vaginal deliveries
cThere were 3 trials of vaginal delivery (1 woman with an episiotomy and placental retention, 1 woman with no other anomaly, and 1 woman with a uterine
rupture and a vaginal laceration)
dHemorrhagic normal third stage: excessive blood loss during a normal separation of the placenta from the uterine wall
eThe professionals were unable to select a principal cause for the PPH
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The non-pharmacological procedures, that is, second-
line treatments, are described in Table 5. Manual uterine
examination was reported in 80 % of the PPH after vagi-
nal deliveries. Intrauterine balloon treatment was still
infrequent during the study period. Vessel embolization
by interventional imaging was 3.4 times [95 % CI:
2.58–4.63] more frequent among women with cesar-
eans than those with vaginal deliveries (10.0 vs. 2.9 %).
At the same time, surgical procedures were less frequent
after cesarean than vaginal deliveries (25.5 vs. 42.6 %)
[RR = 0.6; 95 % CI: 0.52–0.68]. After excluding surgical
procedures of the perineum, the RR for surgical proce-
dures was 5.36 [95 % CI:4.22–6.82] after cesarean com-
pared with vaginal deliveries (23.5 vs. 4.4 %). Women
with cesareans required transfusions more often (44.4
vs. 12.7 %) [RR = 3.5; 95 % CI: 3.11–3.95] (Table 5).
Again, if we limit the comparison of the two types of
delivery by defining PPH by the same volume of blood
loss (>1000 mL), the results again pointed in the same
direction, with arterial embolization still more frequent
but no longer statistically significantly (10.0 % vs. 8.1 %;
RR = 1.24 [95 % CI: 0.89–1.71] and transfusion of packed
red blood cells [RR = 1.27; 95 % CI:1.12–1.44] more
frequent for cesarean deliveries [data not shown] (see
Additional file 2: Table S2).
Discussion
Study strengths and limitations
This study covered 129,110 of the 786,559 deliveries
recorded in France in 2011 and accounted for 32.82 % of
all deliveries during the 6 months of the study [32].
However, private hospitals participated at a lower rate
than the other types of hospitals (Table 1). Among the
20 perinatal networks that agreed to support the study,
the participation rate was satisfactory (78.79 %). This
participation was total (100 % of their maternity units)
for 50 % of the networks. The definition of PPH was
standardized and the data collection prospective, in a
daily clinical setting. Substantial quality control to
verify data input quality was performed in 30 % of the
maternity units.
The choice to use different definitions of PPH acco-
rding to mode of delivery can be debated. Based on a
discussion between obstetricians, it was intended to
facilitate the participation of the obstetrics professionals
in the maternity units. A large number of obstetricians
considered that a threshold of 500 mL for cesareans was
inappropriate, both because it would considerably in-
crease the number of PPH among cesareans and because
the amniotic fluid aspired at the moment of incision
makes this threshold unreliable. Moreover, although the
Table 5 Non-pharmaceutical curative second-line procedures performed for PPH






Crude RRf [95 % CI] p value
Manual uterine examination 80.0 - - -
Intrauterine balloon 0.9 1.0 1.06 [0.47–2.39] .9
Radiologic artery embolization 2.9 10.0 3.46 [2.58–4.63] <.0001
Surgical proceduresa 42.6 25.5 0.60 [0.52–0.68] <.0001
B-Lynch suture 0.3 3.9 - -
Ho Cho suture 0.1 3.5 - -
Hypogastric arterial ligation 0.3 6.5 - -
Other vessel ligation 0.5 10.3 - -
Cervical suture 3.0b 0.7 - -
Suture of a vaginal laceration 39.9 2.5 - -
Hysterectomy 0.4 5.6 - -
Repair of uterine wound closure - 2.8 - -
Evacuation of hematoma of the abdominal wall 0 0.7 - -
Other surgery 0.3c 6.1d - -
Transfusion of packed red blood cells 12.7 44.4 3.5 [3.11–3.95] <.0001
Maternal death 0.03e 0 - -
aRegardless of the type of surgical procedure
bAmong women with a cervical laceration, we note 3 emergency hysterectomies
cCorresponds to 8 uterine ruptures sutured without a hysterectomy and one traction rotation of the cervix with forceps
dCorresponds to 3 uterine ruptures sutured without a hysterectomy and 6 sutured bladder lacerations ; 2 laparotomies with ablation of clots without active
bleeding ; 1 laparatomy for a retroperitoneal hematoma, and a ruptured hepatic adenoma ; 2 laparotomies with reoperation of the uterus and evacuation of
intrauterine clots
eOne maternal death
fCesareans vs. vaginal deliveries
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French guidelines of December 2014 clearly define PPH
as blood loss ≥500 mL, regardless of mode of delivery,
the definition was less clear in the 2004 guidelines, in
effect during the study period [33, 34]. We further
note that the American College of Obstetricians and
Gynecologists uses the same definition we did: > 500 mL
for vaginal deliveries and > 1000 mL for cesareans [35].
Another criticism is that the determination of the
volume of blood loss was not more objective. Visual
estimates of blood loss are known to be inaccurate and
associated with an underestimation of blood loss [11, 36].
However, it is the first-line method available to physicians
in the immediacy of decision making and it is widely used
in French maternity wards. In a large European trial, the
use of a collection bag compared with visual estimates of
blood loss after vaginal delivery was not found to reduce
the rate of severe PPH [37].
Interpretation
The incidence of PPH (>500 mL) after vaginal delivery
was 3.36 % [95 % CI: 3.25–3.47 %], slightly lower than
the percentage reported in several studies [14, 19, 23].
However, the studies that measured blood loss object-
ively, as opposed to subjectively, have showed higher
prevalence rates [23]. Elsewhere, there is a wide variation
in PPH rates throughout the world [23]. The incidence
of severe PPH (≥1000 mL) after vaginal delivery was
1.11 % [95 % CI: 1.05–1.18], lower than reported by
some authors [17, 38] and similar to the results in
another French study [20]. Here again, this prevalence
varies widely internationally [23, 30]. The incidence of
PPH (>1000 mL) after cesareans was 2.83 % [95 % CI:
2.63–3.04 %], similar to other reported rates [37, 39],
and the incidence of severe PPH (≥1500 mL) after cesar-
eans was 1.0 % [95 % CI: 0.88–1.13 %]. It is not always
easy to compare the published studies because the def-
inition of severe PPH varies from study to study and is
not often defined simply as a volume of blood loss
[20, 21, 25]. Finally, despite definitions of PPH that
vary by mode of delivery, authors generally calculate
an overall incidence of PPH without distinguishing the
mode of delivery [12, 18, 29, 40–42]. The incidence of
PPH here varied according to maternity unit level,
contrary to the results in another French study [20].
The incidence of PPH varied in our study according to
number of deliveries only for the cesareans; this is
unsurprising because patients at risk of PPH are most
often referred to Level III units, which are also the
largest. Nonetheless, a US study found a higher rate of
PPH in the lowest volume rural hospitals than in non-
rural hospitals, for both cesareans and spontaneous
vaginal deliveries [43].
Blood loss volume was measured subjectively in 21.5 %
of the PPH after vaginal delivery, compared with 38.9 % of
those after cesareans. This may explain in part the more
frequent use in France of second-line treatments, which
underlines a possible delay in diagnosis [14]. It should be
noted that in France, most maternity units do not rou-
tinely perform blood counts, except in PPH identified by
the volume of blood loss or by clinical signs of hypovol-
emia or anemia. Finally, active management of the third
stage of labor was performed for only 79.8 % of the PPH
after vaginal delivery and 90.7 % after cesareans, although
the 2004 French guidelines recommended this manage-
ment routinely for all deliveries [33]: active management
of the third stage of labor, including the prophylactic
application of uterotonics, is considered a key point in the
prevention of PPH [44]. Oxytocin is the agent used most
frequently, even after cesareans. The percentage of active
management of the third stage of labor has increased in
France since 2006 [45]. It is probable that the national rate
in 2015 is still better, after the 2014 publication of the
updated French guidelines. Our results are consistent with
those from a database collecting information regularly
from volunteer French maternity units [46].
Unsurprisingly, uterine atony was the most common
cause of PPH both for vaginal and cesarean deliveries
(Table 4), but our results highlight the frequency of mul-
tiple causes in the same patient. The third leading cause of
PPH after vaginal delivery was perineal tears or lacera-
tions, and the fourth leading cause episiotomies. Episioto-
mies remain relatively common in France, with an overall
rate around 28.5 % [46] and a rate in nulliparas around
45 % [46, 47]. The second leading cause of PPH during
cesareans in our study was related to the surgical incision
(16.4 %). To our knowledge, this is the first study to detail
the causes of PPH associated with surgical procedures
among the cesareans with PPH. The extension of the uter-
ine incision at cesarean delivery is well known to obstetri-
cians [21, 48, 49], but other causes of PPH after a cesarean
can include uterine bleeding due to incision into the
muscle, active bleeding persisting after suture of the inci-
sion, and hematomas, either subperitoneal or of the broad
ligament or the uterine wall, or due to an incision either
transplacental or through a highly vascularized lower
segment. The rate of relaparotomy after cesarean delivery
is thought to be around 1.5–2 % [49–51]. Levin et al.
found that 89.3 % of the indications for relaparotomy after
cesareans were associated with hemorrhagic complica-
tions (28 relaparotomies for 17,482 cesareans) [50]. The
surgical incision during cesareans is therefore associated
with immediate or secondary hemorrhagic complications,
to which we must add non-hemorrhagic intraoperative or
postoperative complications [48, 52, 53]. These risks of
immediate (not to mention longer-term) complications
must encourage obstetricians to limit the number of
cesareans and therefore to avoid choosing to perform first
cesareans, especially among nulliparous women.
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The pharmacologic treatments used in this study show
notable use of tranexamic acid, fibrinogen, and recom-
binant activated factor VII; they were used more often
after cesareans and signal that these deliveries entailed
more serious PPH.
Among the non-pharmacological curative second-line
procedures, we see that the intrauterine balloon tampon-
ade was still little used in France at that time, unlike in
UK maternity units [54]. Use of balloon tamponade is
relatively recent in France, and the first small French
series was not published until 2012 [55]. This technique
has since been spreading among French maternity units
and is now proposed after failure of prostaglandin treat-
ment by the 2014 French guidelines [34]. We also note
that embolization is fairly frequent in France, particu-
larly after cesareans, somewhat surprisingly. That is, one
would expect more revision surgery after cesareans, but
that may be explained by the delayed character of PPH
in the recovery room or during postpartum monitoring,
and by easy access to vascular embolization platforms in
larger maternity units, outside the Paris region. Emergency
hysterectomy was, as in the literature, more frequent after
cesareans (5.6 %) [28, 56–59]. Second-line treatment of
PPH remains challenging, since we lack sufficient scientific
evidence from randomized controlled trials for choosing
the specific treatment.
After vaginal deliveries, 12.7 % of the women with
PPH had transfusions (vs. 44.4 % for the cesareans with
PPH). The transfusion rate after vaginal deliveries
reported here is higher than that observed in other
studies [14, 60]. The excess risk of transfusion after
cesareans also varies according to parity, number of
previous cesareans, and type of cesarean (elective vs.
emergency), but these factors were not collected in this
study [61–63].
Conclusion
The incidence of PPH after vaginal delivery was 3.36 %
and after a cesarean 2.83 %. The incidence of severe
PPH after vaginal delivery was 1.11 % and after a
cesarean 1.00 %. This incidence rate varied according to
maternity unit characteristics. The principal cause of
PPH for both modes of delivery was uterine atony,
which is therefore the obstetric complication for which
improvement in prevention, identification, and manage-
ment remain important priorities in maternity units.
It is essential to have harmonized international defi-
nitions of PPH after vaginal and cesarean deliveries,
whether it is volume or method of collection of blood
loss, in order to facilitate the comparison of the inci-
dence and prevalence rates of PPH in both developed
and low-income countries. Moreover, studies should
seek to assess the methods to optimize immediate diagno-
sis of PPH, such as improvements in the visual estimates
of blood loss (simulations of clinical scenarios, posters
with photographs of blood losses accompanied by a cali-
brator to help determine the blood volume) or weighing
the lost blood.
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